methoxy-polyethylene glycol-epoetin beta
SpainDrugs containing this active substance
-
It is used to treat anemia caused by chronic kidney disease in adults and children (from 3 months up to under 18 years of age) who are already receiving prior treatment with erythropoiesis-stimulating agents.
Form: solution for injection in a pre-filled syringe
Active substance Dosage methoxy-polyethylene glycol-epoetin beta 100 µg Manufacturer: Roche Registration Gmbh
-
It is used to treat anemia caused by chronic kidney disease in adults and children (from 3 months up to less than 18 years old) who are already receiving prior treatment to stimulate red blood cell production.
Form: solution for injection in a pre-filled syringe
Active substance Dosage methoxy-polyethylene glycol-epoetin beta 120 µg Manufacturer: Roche Registration Gmbh
-
It is used to treat anemia with symptoms (such as tiredness, weakness, or shortness of breath) caused by chronic kidney disease in adults and children between 3 months and under 18 years of age.
Form: solution for injection in a pre-filled syringe
Active substance Dosage methoxy-polyethylene glycol-epoetin beta 150 µg Manufacturer: Roche Registration Gmbh
-
It is used to treat anemia caused by chronic kidney disease in adults and children (from 3 months up to under 18 years of age) who are already receiving prior treatment to stimulate red blood cell production.
Form: solution for injection in a pre-filled syringe
Active substance Dosage methoxy-polyethylene glycol-epoetin beta 200 µg Manufacturer: Roche Registration Gmbh
-
It is used to treat anemia caused by chronic kidney disease in adults and children (from 3 months up to less than 18 years old) who are already receiving previous treatment to stimulate red blood cell production.
Form: solution for injection in a pre-filled syringe
Active substance Dosage methoxy-polyethylene glycol-epoetin beta 250 µg Manufacturer: Roche Registration Gmbh
-
It is used to treat anemia caused by chronic kidney disease in adults and children (from 3 months up to less than 18 years old) who are already receiving prior treatment with erythropoiesis-stimulating agents.
Form: solution for injection in a pre-filled syringe
Active substance Dosage methoxy-polyethylene glycol-epoetin beta 30 µg Manufacturer: Roche Registration Gmbh
-
It is used to treat anemia caused by chronic kidney disease in adults and children (from 3 months up to less than 18 years old) who are already receiving prior treatment to stimulate red blood cell production.
Form: solution for injection in a pre-filled syringe
Active substance Dosage methoxy-polyethylene glycol-epoetin beta 50 µg Manufacturer: Roche Registration Gmbh
-
It is used to treat anemia caused by chronic kidney disease in adults and children (from 3 months up to less than 18 years of age) who are already receiving prior treatment with erythropoiesis-stimulating agents.
Form: solution for injection in a pre-filled syringe
Active substance Dosage methoxy-polyethylene glycol-epoetin beta 75 µg Manufacturer: Roche Registration Gmbh